Literature DB >> 12522817

Study of novel chitosan-gelatin artificial skin in vitro.

Jinshu Mao1, Liguo Zhao, Kang De Yao, Qingxin Shang, Guanghui Yang, Yilin Cao.   

Abstract

A novel absorbable scaffold composed of chitosan and gelatin was fabricated by freezing and lyophilizing methods, resulting in an asymmetric structure. This bilaminar texture is suitable for preparing a bilayer skin substitute. The methods employed to confirm the applicability of this chitosan-gelatin scaffold as an ideal skin substitute were a water uptake ability test, in vitro fibroblast proliferation, and scaffold tests in which fibroblasts were co-cultured with keratinocytes. The chitosan-gelatin scaffolds were more wettable and adsorbed more water than did chitosan alone. In static cell culture the thinner scaffold is better than the thicker one, and because of diffusion limitations in the scaffold, culture time must be within 3 weeks before transplantation to living tissues. Keratinocytes were co-cultured with fibroblasts in chitosan-gelatin scaffolds to construct an artificial bilayer skin in vitro. The artificial skin obtained was flexible and had good mechanical properties. Moreover, there was no contraction observed in the in vitro cell culture tests. The data from this study suggest that chitosan-gelatin scaffolds are suitable for skin tissue engineering goals. Copyright 2002 Wiley Periodicals, Inc. J Biomed Mater Res 64A: 301-308, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522817     DOI: 10.1002/jbm.a.10223

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  30 in total

1.  Fabrication and evaluation of chitosan-gelatin based buckling implant for retinal detachment surgery.

Authors:  Hui Chen; Zhi Zhao; Yahong Zhao; Yumin Yang
Journal:  J Mater Sci Mater Med       Date:  2010-08-14       Impact factor: 3.896

2.  Application of collagen-chitosan/fibrin glue asymmetric scaffolds in skin tissue engineering.

Authors:  Chun-mao Han; Li-ping Zhang; Jin-zhang Sun; Hai-fei Shi; Jie Zhou; Chang-you Gao
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

Review 3.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

4.  Monitoring of metabolite gradients in tissue-engineered constructs.

Authors:  Olga A Boubriak; Jill P G Urban; Zhanfeng Cui
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

5.  Genipin-crosslinked chitosan/gelatin blends for biomedical applications.

Authors:  Valeria Chiono; Ettore Pulieri; Giovanni Vozzi; Gianluca Ciardelli; Arti Ahluwalia; Paolo Giusti
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

Review 6.  Evaluation of corneal cell growth on tissue engineering materials as artificial cornea scaffolds.

Authors:  Hai-Yan Wang; Rui-Hua Wei; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

7.  Preparation and characterization of electrospun PCL/PLGA membranes and chitosan/gelatin hydrogels for skin bioengineering applications.

Authors:  Rose Ann Franco; Thi Hiep Nguyen; Byong-Taek Lee
Journal:  J Mater Sci Mater Med       Date:  2011-07-31       Impact factor: 3.896

Review 8.  The useful agent to have an ideal biological scaffold.

Authors:  Raziyeh Kheirjou; Jafar Soleimani Rad; Ahad Ferdowsi Khosroshahi; Leila Roshangar
Journal:  Cell Tissue Bank       Date:  2020-11-22       Impact factor: 1.522

9.  A 3D biodegradable protein based matrix for cartilage tissue engineering and stem cell differentiation to cartilage.

Authors:  Neethu Mohan; Prabha D Nair; Yasuhiko Tabata
Journal:  J Mater Sci Mater Med       Date:  2008-06-17       Impact factor: 3.896

10.  Real time in vitro studies of doxorubicin release from PHEMA nanoparticles.

Authors:  Raje Chouhan; Ak Bajpai
Journal:  J Nanobiotechnology       Date:  2009-10-20       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.